We observed the clinical and microbiological characteristics of several stages of bloodstream infections (BSI), as well as the mortality attributed to it in a tertiary hospital in the northeast of Brazil (in the city of Maceió, Alagoas). A prospective cohort of 143 patients who had at least one positive blood culture was enrolled in the study. Their clinical evolution was followed up for 30 days from October 2005 to December 2006. The relation among the qualitative variables was verified through Chi-square test. The significance level was 5%. The statistical package adopted was SPSS 15.0 for Windows. Up to the thirtieth day, 30.1% of the patients presented bacteremia and 69.9% developed sepsis. Among these, 20.3% developed severe sepsis and 10.5% septic shock. The mortality attributed to it was 37.8%. In bacteremia, sepsis, severe sepsis, and septic shock conditions, mortality rates were 9.3%, 50%, 65.5%, and 84.6%, respectively. Respiratory (32.2%) and urinary (14%) sources and the ones related to central venous catheter (14%) were prevalent. In the wards 55.12% of the cases developed sepsis, whereas in the intensive care units, the rate was 87.69% (p<0.05). Chronic renal failure, diabetes melitus, and neuropathy were present in 21.7%, 26.6%, and 29.4% of the cases, respectively. Coagulase-negative Staphylococcus (25.9%), Staphylococcus aureus (21%), and Klebsiella pneumoniae (14%) were the most present microorganism in the sample. The high morbidity and mortality rates in this study are attributed to the lack of knowledge on BSI characteristics and on instituted protocols for detection and treatment in early stages.
Journal Information
Vol. 14. Issue 2.
Pages 175-179 (March - April 2010)
Vol. 14. Issue 2.
Pages 175-179 (March - April 2010)
Original article
Open Access
Clinical and microbiological characteristics of bloodstream infections in a tertiary hospital in Maceió, Alagoas, Brazil
Visits
2795
This item has received
Article information
Abstract
Keywords:
bloodstream infections
blood cultures
bacteremia
spesis
Full text is only aviable in PDF
References
[1]
D. Pittet.
Nosocomial bloodstream infections: secular trends in rates, mortality, and contributions to total hospital deaths.
Arch Intern Med, 155 (1995), pp. 1177-1184
[2]
W.R. Jarvis.
Selected aspects of the socioeconomic impact of nosocomial infections. Mortality, cost, and prevention.
Infect Control Hosp Epidemiol, 17 (1996), pp. 552-557
[3]
B. Digiovine, C. Chenoweth, C. Watts, M. Higgins.
The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit.
Am J Respir Crit Care Med September, 160 (1999), pp. 976-981
[4]
G.R. Bernard, J.L. Vincent, P.F. Laterre, et al.
Efficacy and safety of recombinant human activated protein C for severe sepsis.
The New England Journal of Medicine, 344 (2001), pp. 699-709
[5]
M.L. Pizzolatti, R.D. Moritz, J. Andrade.
Avaliação do conhecimento dos profissionais da área de medicina de urgência sobre os critérios de definição de SIRS, Sepse, Sepse Grave e Choque Séptico.
Revista Brasileira Terapia Intensiva (RBTI), 16 (2004), pp. 210-214
[6]
E.H. Ibrahim, G. Sherman, S. Ward, et al.
The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting.
Chest, 118 (2000), pp. 146-155
[7]
J.A. Russel.
Management of Sepsis.
N. Engl. J Med October 19, 355 (2006), pp. 16
[8]
Fernandes AT, Furtado JJD, Porfírio FMV, Cavalcante NJF. Infecção hospitalar da corrente sanguínea. In: Fernandes AT. (editores) Controle de infecção hospitalar e suas interfaces na área de saúde. 2000; cap. 23:580-606.
[9]
P.R.A. Carvalho, E.A. Trotta.
Avanços no diagnóstico e tratamento da sepse.
J Pediatr (Rio J), 79 (2003), pp. S195-S204
[10]
D. Angus, W.T. Linde-Zwirble, J. Lidicker, et al.
Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.
Crit Care Med, 29 (2001), pp. 1303-1310
[11]
K.G. Luz, L.A.C. Marinho, Tavares W. Sepse.
Rotinas de diagnóstico e tratamento das doenças infecciosas e parasitárias, pp. 941-950
[12]
N.M. Hallage.
Epidemiologia das infecções associadas a cateter intravascular.
Infecção associada ao uso de cateteres vasculares., 3 ed., APECIH – Associação Paulista de Estudos e Controle de Infecção Hospitalar, (2005),
[13]
American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.
Crit Care Med, 20 (1992), pp. 864-874
[14]
Pinheiro S. Predição de Risco de Infecção Hospitalar para Pacientes em Unidade de Terapia Intensiva. Mestrado em INFECTOLOGIA. Universidade Federal de São Paulo, UNIFESP, Brasil. Ano de Obtenção: 1998.
[15]
E. Silva, C. Pinheiro, V. Michel Júnior.
Epidemiologia.
Revista Brasileira de Terapia Intensiva - RBTI/Consenso Brasileiro de Sepse – Parte I. abr/jun, 16 (2004), pp. 97-108
[16]
M.S. Rangel-Frausto, D. Pittet, M. Costigan, et al.
The natural history of the the systemic inflammatory response syndrome (SIRS). A prospective study.
JAMA, 273 (1995), pp. 117-123
[17]
C. Alberti, C. Brun-Buisson, H. Burchardi, et al.
Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study.
Intensive Care Med, 28 (2002), pp. 108-121
[18]
G.S. Martin, D.M. Mannino, S. Eaton, et al.
The epidemiology of sepsis in the United States from 1979 through 2000.
N Engl J Med, 348 (2003), pp. 1546-1554
[19]
R.L.L. Lemos, C.M.N. David, G.M.M. Oliveira, D.A. Amitrano, R.R. Luiz.
Associação do SOFA com a mortalidade de idosos com sepse grave e choque séptico.
RBTI, 17 (2005), pp. 246-250
[20]
C. Brun-Buisson, F. Doyon, J. Carlet, et al.
Bacteremia and severe sepsis in adults: a multicenter prospective survey in ICUs and ward of 24 hospitals. French Bacteremia Sepsis Study Group.
Am J Repor Crit Care Med, 154 (1996), pp. 617-624
[21]
E.A.S. Medeiros, F.G. Menezes, L.M.C. Valle.
Pneumonias bacterianas associadas à assistência à saúde.
Prevenção das infecções hospitalares do trato respiratório, 2 ed., APECIH – Associação Paulista de Estudos e Controle de Infecção Hospitalar, (2005),
[22]
CDC. Guidelines for the Prevention of Catheter-Related Infections. MMWR Recommendations and Reports 2002/51(RR10); 1-26.
[23]
F.R. Menegotto, S.U. Picoli.
Staphylococcus aureus oxacilina resistente (MRSA): incidência de cepas adquiridas na comunidade (CA-MRSA) e importância da pesquisa e descolonização em hospital.
RBAC, 39 (2007), pp. 147-150
[24]
J. Ribeiro, J.M. Boyce, P.Q. Zancanaro.
Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) among patients visiting the emergency room at a tertiary hospital in Brazil.
Braz J Infect Dis. feb, 9 (2005),
[25]
E. Silva, C. Pinheiro, V. Michel Júnior.
Epidemiologia.
Revista Brasileira de Terapia Intensiva - RBTI/Consenso Brasileiro de Sepse – Parte I. abr/jun, 16 (2004), pp. 97-108
[26]
J. Rello, M. Ricart, B. Mirelis, et al.
Nosocomial Bacteremia in a medical-surgical intensive care unit: epidemiologic characteristics and factors influencing mortality in 111 episodes.
Intensive Care Med, 20 (1994), pp. 94-98
[27]
E. Silva, M.A. Pedro, A.C.B. Sogayar, et al.
Brazilian Sepsis Epidemiological Study (BASES study).
Critical Care, 8 (2004), pp. R251-R260
[28]
C. Brun-Buisson, F. Doyon, J. Carlet, et al.
Incidence, risk factors, and outcome of severe sepsis and sepsis shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis.
JAMA, 274 (1995), pp. 968-974
[29]
K.E. Sands, D.W. Bates, P.N. Lanken, et al.
Epidemiology of sepsis syndrome in 8 academic medical centers. Academic Medical Center Consortium Sepsis Project Working Group.
JAMA, 278 (1997), pp. 234-240
[30]
R.P. Dellinger.
The surviving sepsis campaign.
Revista Brasileira Terapia Intensiva (RBTI), 16 (2004), pp. 257-260
[31]
R.P. Dellinger, et al.
Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2008.
Crit Care Med, 36 (2008), pp. 296-327
Copyright © 2010. Elsevier Editora Ltda.. All rights reserved